Women are subjected to increased financial burden to treat underlying abnormal uterine<unk> . Annually, they loose  USD $2,000.00 on account of work absences. Hormonal medications range from USD $172.00 for contraceptive pills, USD $930.00 for levonorgestrel IUD and upwards of USD $30,000.00 for hysterectomies.
Dysfunctional uterine bleeding cost-effectiveness of therapy
Hyperemesis gravidarum cost-effectiveness of therapy
Menopause cost-effectiveness of therapy
Dysfunctional uterine bleeding primary prevention
Dysfunctional uterine bleeding future or investigational therapies
Endometrial cancer other diagnostic studies
Endometriosis other diagnostic studies
Endometrial hyperplasia other diagnostic studies